Проф. д-р Ердал Карайоз - визитка

Prof. Dr. Erdal Karayoz

Prof. Phd. Erdal Karaöz

BRIEF INFORMATION:
Specialist:
regenerative medicine

CV and professional development

Professor Dr. Erdal Karayoz was born in 1963 in the town of. He was born in 1963 in Izmir, Turkey. He graduated from Dikle University in 1986 and received his Ph.D. from the Department of Histology and Embryology, Gazi University School of Medicine in 1994. In 2005, he was a visiting scholar at the Joslin Diabetes Center, Harvard Medical School. Upon his return, Prof. Karayöz established, Turkey's first, stem cell research center at Kocaeli University in 2006. He was the director of the research center and head of the stem cell department from 2007 to 2014. During these years, he published more than 70 original research articles on stem cells and cell biology in various international scientific journals. Prof. Karaioz has authored and co-authored dozens of books on Histology and Embryology and Stem Cells.

Memberships and publications

Prof. Dr. Erdal Karayoz has organized over 23 national and international workshops on basic stem cell technologies and IPS. He has participated in over 40 national and international research projects as a principal investigator or researcher.

Prof. Dr. Karaioz is an active member of many academic and professional institutions including:
  • TERMİS
  • European Hematology Association
  • European Association for Cancer Research
  • Euroscience
  • Turkish Society for Electron Microscopy
  • Turkish Society of Hematology
  • International Society for Cellular Medicine

He was the head of the Stem Cell and Cell Therapies Society from 2013 to 2016. At the end of September 2014, he joined Liv Hospital as Head of Stem Cells and Regenerative Medicine. In this department, cellular products such as fibroblasts, chondrocytes and mesencephalic stem cells are derived according to all FDA and GMP regulations. These cells are used in the treatment of many different diseases.

Clinical areas of interest

Prof. Dr. Karaioz's medical areas of interest and practice is the application of stem cells for the treatment of:
  • Autism
  • Epilepsy
  • Multiple sclerosis
  • Muscular dystrophy
  • Diabetes and diabetic foot
  • Chronic obstructive pulmonary disease - COPD
  • Tennis elbow
  • Injuries of the brain and spinal cord
  • Rheumatoid arthritis
  • Damage to articular cartilage
  • Crohn's disease
  • Optic neuropathy and others

Currently prof. Karayoz and his colleagues are focused on clinical trials for the treatment of incurable diseases, especially neuromuscular degenerative disorders (Duchenne muscular dystrophy, cerebral palsy, spinocerebellar/Frederich ataxia, hypoxic encephalopathy, spinal cord injury, etc.), through the administration of umbilical cord-derived mesenchymal stem cells.

Additional information

Проф. д-р Ердал Карайоз - превю

Prof. Dr. Erdal Karayoz

What methods of treatment does prof. Karayoz in his practice?

There are two different methods of stem cell treatment:

  • Allogeneic - the patient receives stem cells from a suitable donor.
  • Autologous - the patient receives their own.

Prof. Karayoz - methods for allogeneic cell implantation:

  • Allogeneic umbilical cord-derived mesenchymal stem cell MSCs - MSCs have the ability to differentiate into three germ layers, accumulate in damaged tissue or inflamed areas, promote tissue repair, and modulate the immune response. This cell type has many advantages. Mesenchymal stem cells (MSCs) form the group of stem cells that are most commonly used in clinical practice. Much research is being conducted on their regenerative characteristics and it is clear that they have a beneficial effect on the repair processes of many damaged tissues. MSC are used in clinical trials because of their self-regeneration anddifferentiation abilities, their role in tissue repair, and their immunosuppressive and neuroprotective effects.
  • Allogeneic cultured placentas derived from multipotent mesenchymal stromal cells - Using this type of stem cells, one can achieve: improving endothelial function, stimulating angiogenesis and activating the body's own regenerative potential of its own stem cells.

Prof. Karayoz - Methods for autologous cell implantation

  • Stromal Vascular Fraction (SVF)

SVF is derived from the patient's own adipose tissue. Adipose tissue is a rich and very convenient source of stem cells for therapeutic approaches in regenerative medicine. The stromal vascular fraction is a cell extract that is obtained in the laboratory from the body's own fat. SVF cells are obtained by liposuction and contain multiple cell types, including adipose-derived stem cells (ADSCs), mesenchymal and endothelial progenitor cells, leukocyte subtypes, lymphoid cells, pericytes, and vascular smooth muscle cells. SVF cells are processed such that they contain a reproducible and consistent composition of heterogeneous cells. When processed and administered, adipose tissue-derived SVF cells can differentiate into different tissue types, maintain neovascularization, replace cells, and repair traumatic problems.

  • Autologous chondrocyte implantation (ACI)

In this method, mesenchymal stem cells are isolated from the patient's own cartilage tissue. Autologous implantation is a relatively new, advanced procedure used to treat isolated articular cartilage defects of the knee. ACI is also performed for patella (knee cap) defects. Autologous chondrocyte implantation is a two-stage surgical procedure.

First procedure

The first procedure is performed arthroscopically in less than 30 minutes. The surgeon takes a small piece of articular cartilage from the patient's knee. This cartilage biopsy is then sent to a lab where it is enzymatically processed to isolate chondrocytes, which are the cells that produce cartilage. Once these chondrocytes are obtained, they are sent back to the surgeon approximately 6 to 8 weeks later for implantation.

Second stage

The second-stage surgery is an open procedure in which a small patch is sewn over the plastic cartilage defect. The chondrocytes that are collected are injected under this patch, where they adhere to the patient's knee to form what is called hyaline-like cartilage, which resembles the joint's own cartilage. After implantation, there is a period of limited loading for up to 8 weeks. During this time, physical therapy is prescribed to improve range of motion and muscle strength. The surgeon may also recommend the use of robotic passive rehabilitation to ensure the success of the procedure. Return to light sports activities is usually allowed after approximately 6 months with return to full sports activities between 9 and 12 months after the procedure. The overall success rate of ACI is approximately 85%.

How do Prof. Dr. Erdal Karayoz and his colleagues apply stem cells?

Intravenous injection

Based on clinical data and research, stem cells cross the blood-brain barrier when injected systemically.

Procedure

The intravenous delivery method is a very simple process. A catheter is inserted into the patient's vein. Usually, sedation is not required for this procedure. The entire process of intravenous injection of stemhas less than 45 minutes.

Lumbar puncture

Procedure

This is a procedure used to access the cerebrospinal fluid of the brain and spinal cord and helps deliver stem cells directly into the cerebral spinal fluid, bypassing the blood-brain barrier. This is the least invasive method of delivering stem cells directly into the central nervous system.

Intramuscular and intra-articular injection of stem cells

Stem cells are injected directly into the injured muscle or joint.

Work streams:

Part of the team:

Болница Лив 002

Liv Hospital

Liv Hospital's mission is to improve the health of all our international patients by setting the standard of excellence in personalized patient care.

Last viewed in section
"Doctors."

Pin It on Pinterest

Shares
Share This

Register

  • Enter username. It can NOT be changed after creating the account.
  • Please enter email
  • To make sure you don't get confused when typing, please repeat your email again.
  • Enter your password. Minimum length of 8 characters.
    The password must have a minimum strength of Medium
    Strength indicator
  • Enter your password again.
  • Please accept our terms of use. You can read them here.

Request an appointment

Login to your account:

If you don't have a registration don't hesitate - register. You will be able to comment without hindrance.

Our offices at home and abroad:

Head office Sofia:

Str. General Ivan Kolev, 33 B Bulgaria, Sofia

Office Burgas:

Str. Ivan Vazov 75 Bulgaria, Burgas 8000

Plovdiv office:

Blvd. Hristo Botev 92, RILON Business Centre, floor 2 Bulgaria, Plovdiv

Shumen Office:

Str. Panayot Volov No.2 Bulgaria, Shumen.

Macedonia Office:

Bane Andreev Ronkata #2, 1400 Veles, Macedonia